By targeting aldosterone synthesis directly, baxdrostat offers a novel mechanism for addressing resistant hypertension.
Celestine Van Sertima, PharmD Candidate
Advertisement
Articles by Celestine Van Sertima, PharmD Candidate
Oral semaglutide delivers significant weight loss in OASIS trials, offering needle-free obesity therapy.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Tirzepatide Cuts MACE Risk in Diabetes With Heart Disease
2
CVS Health Expands GLP-1 Access With $29 Visits, Lilly Deal
3
FDA Approves mFlusiva, the First mRNA-Based Influenza Vaccine
4
Q&A: Prepare for FDA Inspection on Compounded GLP-1s
5